London & Capital Asset Management Ltd
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1767559
London, X0
Position in TMO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$390,015,292
-$65,557,569 QoQ
Shares Held
793,472
+0.9% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
4.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026London & Capital Asset Management Ltd holds $390,015,292 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
793,472 | $390,015,292 |
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $390,015,292 | 793,472 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $455,572,861 | 786,216 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $58,681,114 | 120,987 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $51,152,022 | 126,158 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $54,562,835 | 109,652 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,646,679 | 68,521 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,602,870 | 60,790 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $32,402,482 | 58,594 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,743,402 | 70,101 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $37,000,309 | 69,708 | Shares | Other | 2024-01-30 | |
| 2023-09-30 | $33,003,296 | 65,202 | Shares | Other | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||